| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'Susceptibility' found in 3 terms [] and 43 definitions []
| previous 6 - 10 (of 46) nextResult Pages : [1] [2 3 4 5 6 7 8 9 10] | | | | Searchterm 'Susceptibility' was also found in the following services: | | | | |
| | | | | | | |
| |
|
| | | | • View the DATABASE results for 'Gradient Echo' (121).
| | | | Further Reading: | Basics:
|
|
| |
| | | | | |
| |
|
Inhomogeneity is the degree of lack of homogeneity, for example the fractional deviation of the local magnetic field from the average value of the field. Inhomogeneities of the static magnetic field, produced by the scanner as well as by object susceptibility, is unavoidable in MRI. The large value of gyromagnetic coefficient causes a significant frequency shift even for few parts per million field inhomogeneity, which in turn causes distortions in both geometry and intensity of the MR images.
Manufacturers try to make the magnetic field as homogeneous as possible, especially at the core of the scanner. Even with an ideal magnet, a little inhomogeneity is always left and is caused in addition by the susceptibility of the imaging object.
The geometrical distortion (displacement of the pixel locations) are important e.g., for some cases as stereotactic surgery. Displacements up to 3 to 5 mm have been reported. The second problem is the undesired changes in the intensity or brightness of pixels, which may cause problems in determining different tissues and reduce the maximum achievable image resolution.
Image Guidance
| | | | • View the DATABASE results for 'Inhomogeneity' (21).
| | | | Further Reading: | News & More:
|
|
| |
| | | Searchterm 'Susceptibility' was also found in the following services: | | | | |
| | |
| |
|
| | | | | | | | • View the DATABASE results for 'Lung Imaging' (7).
| | | • View the NEWS results for 'Lung Imaging' (3).
| | | | Further Reading: | | Basics:
|
|
News & More:
| |
Chest MRI a viable alternative to chest CT in COVID-19 pneumonia follow-up Monday, 21 September 2020 by www.healthimaging.com | | |
CT Imaging Features of 2019 Novel Corona virus (2019-nCoV) Tuesday, 4 February 2020 by pubs.rsna.org | | |
Polarean Imaging Phase III Trial Results Point to Potential Improvements in Lung Imaging Wednesday, 29 January 2020 by www.diagnosticimaging.com | | |
Low Power MRI Helps Image Lungs, Brings Costs Down Thursday, 10 October 2019 by www.medgadget.com | | |
Chest MRI Using Multivane-XD, a Novel T2-Weighted Free Breathing MR Sequence Thursday, 11 July 2019 by www.sciencedirect.co | | |
Researchers Review Importance of Non-Invasive Imaging in Diagnosis and Management of PAH Wednesday, 11 March 2015 by lungdiseasenews.com | | |
New MRI Approach Reveals Bronchiectasis' Key Features Within the Lung Thursday, 13 November 2014 by lungdiseasenews.com | | |
MRI techniques improve pulmonary embolism detection Monday, 19 March 2012 by medicalxpress.com |
|
News & More:
| |
| |
| | | | | |
| |
|
Categories of negative oral contrast agents:
Negative oral contrast media are usually based on superparamagnetic particles and act by inducing local field inhomogeneities, which results in shortening of both T1 and T2 relaxation times. Superparamagnetic contrast agents have predominant T2 weighted effects.
Biphasic contrast media are agents that have different signal intensities on different sequences, depending on the concentration at which they are used.
Suitable materials for oral contrast agents should have little or no absorption by the stomach or intestines, complete excretion, no motion or susceptibility artifacts, affordability, and uniform marking of the gastrointestinal tract.
Benefits of negative oral contrast agents are the reduction of ghosting artifacts caused by the lack of signal. Superparamagnetic iron oxides produce also in low concentrations a noticeable signal loss; but can generate susceptibility artifacts especially in gradient echo sequences. Perfluorochemicals do not dilute in the bowel because they are not miscible with water.
High cost, poor availability, and limited evaluations of side effects are possible disadvantages.
Negative oral contrast agents are used e.g., in MRCP, where the ingestion of 600-900 ml of SPIO cancels out the signal intensity of the lumen (in addition after the injection of a gadolinium-based contrast medium, the enhancement of the inflammatory tissues is clearer seen), and in MR abdominal imaging of Crohn's disease in combination with mannitol.
| | | | • View the DATABASE results for 'Negative Oral Contrast Agents' (7).
| | | | Further Reading: | Basics:
|
|
| |
| | | | |
| | | |
|
| |
| Look Ups |
| |